Line Veronika Hjelle

Line Veronika Hjelle serves as Associate Professor in the Department of Clinical Medicine at UiT The Arctic University of Norway. She actively contributes to the Translational Cancer Research Group (TCRG) and the Testicular Cancer and Cancer Survivorship project.

Research Focus
Her work centers on urological oncology with specialized expertise in prostate, bladder, and testicular cancer survivorship. Key investigations include longitudinal patient-reported outcomes following curative treatments, cisplatin-related late effects in testicular cancer survivors, and real-world utilization of neoadjuvant chemotherapy for muscle-invasive bladder cancer. She examines critical intersections between treatment modalities, quality of life metrics, and long-term physiological impacts.

Publication Trends
Analysis of her 2014-2025 publications reveals consistent emphasis on cancer survivorship science, particularly platinum chemotherapy pharmacokinetics and patient-centered outcomes. Recent work (2023-2025) expands into comparative effectiveness of prostate cancer treatments and real-world bladder cancer management, while earlier studies (2014-2018) established foundational insights into testicular cancer survivorship through 20-year longitudinal biomarker monitoring.

Research Infrastructure
She operates within UiT's Translational Cancer Research Group framework and contributes to the Testicular Cancer Survivorship project, leveraging multidisciplinary collaborations evident in co-authorship networks spanning oncology, urology, and epidemiology departments.